Relationship between tumor biomarkers (BM) and efficacy in TH3RESA, a phase 3 study of trastuzumab emtansine (T-DM1) versus treatment of physician’s choice (TPC) in HER2-positive advanced breast cancer (BC) previously treated with trastuzumab and lapatinib.
Sung-Bae Kim
Consultant or Advisory Role - Novartis (U)
Research Funding - II Dong Pharmaceuticals; Novartis
Hans Wildiers
Consultant or Advisory Role - Roche
Honoraria - Roche
Ian E. Krop
Consultant or Advisory Role - Roche/Genentech (U)
Research Funding - Roche/Genentech
Abraham C.F. Leung
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Caroline Trudeau
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Ron Yu
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Sanne de Haas
Employment or Leadership Position - Roche
Antonio Gonzalez-Martin
No relevant relationships to disclose